• Explore /
  • Poster
  • / A randomized, phase II study of repeated rhenium-188-HEDP (rhenium) combined with docetaxel versus docetaxel alone in castration resistant prostate cancer (CRPC) metastatic to bone: The Taxium II trial.

A randomized, phase II study of repeated rhenium-188-HEDP (rhenium) combined with docetaxel versus docetaxel alone in castration resistant prostate cancer (CRPC) metastatic to bone: The Taxium II trial.

Abstract Poster

Authors

null

Joyce M. van Dodewaard-de Jong

VU University Medical Center, Amsterdam, Netherlands

Joyce M. van Dodewaard-de Jong , Haiko Bloemendal , John M. H. de Klerk , Daniela E Oprea-Lager , Otto S. Hoekstra , H Pieter van den Berg , Maartje Los , Aart Beeker , Joe M. O'Sullivan , Henk M.W. Verheul , Alfonsus Johannes Maria van den Eertwegh

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Prostate) Cancer

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer - Advanced Disease

Citation

J Clin Oncol 34, 2016 (suppl; abstr 5081)

DOI

10.1200/JCO.2016.34.15_suppl.5081

Abstract #

5081

Poster Bd #

432

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Annual Meeting

Selection biases in the systematic collection of breast biobank specimens.

Selection biases in the systematic collection of breast biobank specimens.

First Author: Yael Bar

First Author: Orazio Caffo

First Author: Orazio Caffo

First Author: Esther W. Bouman-Wammes